Tata Elxsi is currently trading at Rs. 6799.60, up by 27.50 points or 0.41% from its previous closing of Rs. 6772.10 on the BSE.
The scrip opened at Rs. 6755.15 and has touched a high and low of Rs. 6885.05 and Rs. 6755.15 respectively. So far 3399 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 10 has touched a 52 week high of Rs. 9191.10 on 18-Dec-2023 and a 52 week low of Rs. 6406.60 on 04-Jun-2024.
Last one week high and low of the scrip stood at Rs. 7012.45 and Rs. 6619.75 respectively. The current market cap of the company is Rs. 42699.53 crore.
The promoters holding in the company stood at 43.92%, while Institutions and Non-Institutions held 19.92% and 36.17% respectively.
Tata Elxsi has been chosen as a strategic partner by Skanray, a leading global MedTech R&D and Manufacturing company specialising in diagnostic imaging, critical care and surgery/OT solutions, for advanced surgical imaging core technology and software platform development. This collaboration aims to revolutionise diagnosis and treatment by leveraging cutting-edge technology modules, making them predictable, accurate, and consistent.
Skanray is actively pursuing a long-term strategy to expand its portfolio by including new device families and modalities. This initiative aims to build a suite of reusable modules and components for medical devices, alongside the development of an advanced analytics cloud platform.
Tata Elxsi will lead a software platform-led approach to diagnostics that will support all imaging, critical care and surgical systems from the Skanray family, ensuring interoperability, compatibility and multimodal functionality. This platform will also incorporate the latest technologies and process efficiencies from AI and GenAI.
Combining Skanray's expertise in medical devices, core component technology, systems and applications with Tata Elxsi's domain experience in medical imaging, software platform development, digital capabilities in cloud, AI and analytics, and ready-to-use solution accelerators provides Skanray an opportunity to redefine the landscape of medical technology, with advanced, modular, and yet affordable diagnostics systems.
Tata Elxsi is a global design and technology Services Company and works with customers across industries such as automotive, broadcast, healthcare and telecom for product and software development.
| Company Name | CMP |
|---|---|
| TCS | 4019.50 |
| Infosys | 1811.40 |
| HCL Tech. | 1833.05 |
| Wipro | 553.00 |
| Tech Mahindra | 1661.40 |
| View more.. | |
MoneyWorks4Me rating and ranking of funds for SIP is available to subscribers only. Moneyworks4Me is not a rating and ranking agency, however it is required that users have a way of selecting funds and building a Portfolio. The method used by it are described below to enable users to understand the logic behind the rating and ranking Subscriber will find more details on this in the various content made available from time to time. In case you need more please write to besafe@moneyworks4Me.com
MoneyWorks4Me rates and ranks mutual funds based on the following data-driven system:
Funds ranking in screeners: Performance Consistency and Quality are two parameters used for ranking funds for SIP. The ranking as follows GG, GO, GR, OG, OO, OR, RG, RO and RR.
With the same color-coded funds, the one with the higher Average 3-year rolling returns (over 5 to 10 years), the number that appears in the Performance tag, ranks higher.
Here is the summary:
The third tag Upside Potential is not relevant for SIP. It is relevant for lumpsum investments in Mutual Funds.
Make an informed decision for Stocks
Buy quality Stocks when they are available at reasonable prices and supported by an upward price trend and Sell when they are Overvalued using the Decizen Rating System. Covers 3500+ stocks
Download APP
